|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/61 | |
| A61P 7/04 | |||
| A61P 37/06 |
| (11) | Number of the document | 2991684 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14727380.9 |
| Date of filing the European patent application | 2014-04-27 | |
| (97) | Date of publication of the European application | 2016-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/035590 |
| Date | 2014-04-27 |
| (87) | Number | WO 2014/179184 |
| Date | 2014-11-06 |
| (30) | Number | Date | Country code |
| 201361816790 P | 2013-04-28 | US |
| (72) |
ASWAD, Fred, Jullien, US
|
| (73) |
Bayer HealthCare LLC,
100 Bayer Boulevard P.O. Box 915, Whippany, NJ 07981,
US
|
| (54) | COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE TO COAGULATION FACTOR PROTEINS |
| COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE TO COAGULATION FACTOR PROTEINS |